Skip to main content
TipRanks
Go Ultimate75% OFF

TRex Bio, Inc. (TRXB) AI Stock Analysis

5 Followers
TRXB

TRex Bio, Inc.

(NASDAQ:TRXB)

Rating:―N/A
Action:N/A
Date:―

No summary available

Positive Factors
Negative Factors

TRex Bio, Inc. (TRXB) vs. SPDR S&P 500 ETF (SPY)

-40%-30%-20%-10%0%10%20%30%TRXB-32.93%SPY+13.11%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$83.30M
Dividend Yield
―
Average Volume (3M)
154.36K
Price to Earnings (P/E)
-1.5
Beta (1Y)
1.04
Revenue Growth
―
EPS Growth
―
Country
US
Employees
60
Sector
Healthcare
Sector Strength
51
Industry
Medical - Pharmaceuticals

TRex Bio, Inc. Business Overview & Revenue Model

Company Description

Trex Bio, Inc. engages in the manufacture of immunotherapies for autoimmune and inflammatory diseases. It focuses on studying the regulation of tissue inflammation to develop breakthrough medicines. The company was founded by Houman Ashrafian, Adil D...

TRex Bio, Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (51)

Financial Indicators

TRXB against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
KNSAKNSA80Outperform$7.47B66.0817.27%―58.19%192.34%
CORTCORT76Outperform$7.67B46.5522.94%―30.02%48.80%
Sector *51Neutral$7.86B-0.30-43.30%2.27%22.53%-2.21%
CTORCTOR44Neutral$50.92M-1.20-102.97%―――

* Healthcare Sector Average

Performance Comparison

-50%0%50%100%TRXBCORTKNSACTORCUVLETRADec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
TRXB and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
TRXBTRex Bio, Inc.9.39-4.61-32.93%
CORTCorcept Therapeutics67.79-7.26-9.67%
KNSAKiniksa Pharmaceuticals Ltd. Class A95.0553.56129.09%
CTORCitius Oncology, Inc.0.56-0.57-50.71%
CUVLClinuvel Pharmaceuticals Limited Sponsored ADR4.86-2.19-31.11%
ETRAElectra Therapeutics Inc.8.43-4.82-36.38%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.